Navigation Links
Bioheart Reports Promising Results From SDF-1 Modified MyoCell(R) Therapy in Heart Failure Study
Date:7/24/2008

myoblasts contribute to greater improvement in cardiac function after transplantation compared to non-modified myoblasts," said Dr. Thattaliyath. "This is a significant and encouraging finding, which adds to the growing body of investigational evidence of using autologous myoblasts in the treatment of congestive heart failure and opens the possibility of further study of MyoCell(R) Clinical Therapy."

SDF-1 is a protein with multiple perceived benefits, including angiogenesis (formation of new blood vessels which can provide nutrients to newly engrafted cells) and stem cell homing (attraction of other stem cells to transplantation site for the purpose of helping with the healing process).

The addition of the SDF-1 protein to MyoCell(R) autologous cell therapy results in a genetic modification that may further assist in future treatment for patients suffering from congestive heart failure. Bioheart obtained a worldwide exclusive license from The Cleveland Clinic to patent applications covering certain methods involving SDF-1 filed in the United States and certain foreign countries.

The study, conducted at the University of Florida and partially funded by Bioheart, focused on two primary hypotheses:

-- An increased expression of SDF-1 in the damaged myocardium should provide a strong homing signal for endogenous stem cells involved in myocardial repair.

-- SDF-1 modified myoblasts (SDF-MB) could undergo differentiation in the cardiac environment and assist myocardial performance, and provide a continuous source of SDF-1.

Study objectives included assessment of cardiac function following onset of MI, assessment of cardiac function in the presence and absence of SDF-1 and an assessment of the distribution and phenotype of the transplanted skeletal myoblasts in a total of seven differentiated study groups of approximately five subjects each. MRI assessments were conducted at one, four and eight weeks after the myoblast transplanta
'/>"/>

SOURCE Bioheart, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Final Data From the Bioheart Seismic Trial Suggest Safety, Efficacy of Autologous Stem-Cell Therapy for Treating Congestive Heart Failure
2. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
3. Bradmer reports progression free survival data from previous Phase II glioblastoma multiforme trials
4. GeoVax Reports Progress on Its AIDS Vaccine Technology
5. Peregrine Pharmaceuticals Reports Positive Early Results in Phase II Study of Bavituximab in Breast Cancer
6. MAP Pharmaceuticals Reports Positive Pharmacological Response Data for Migraine Product Candidate at the American Headache Society Annual Meeting
7. Alimera Reports Results From the Three-Month Interim Readout of the Human PK Medidur(TM) FA Study
8. Ardea Biosciences Reports Additional Positive Phase 2a Results for Lead HIV Candidate, RDEA806, Demonstrating Up to 1.9 Log Reduction in Plasma Viral Load with Once-Daily Dosing
9. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
10. Human Genome Sciences Reports Positive Long-Term Data for LymphoStat-B in Patients With Active Systemic Lupus Erythematosus
11. Synvista Therapeutics Reports Results of Three Phase 2 Clinical Trials of SYI-2074 in Diabetic Patients with Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)...  Bio-Techne Corporation (NASDAQ: TECH ) announced today ... the new Simple Plex platform through its Proteins Platform ... re-branding of the previously acquired CyPlex instrument platform from ... transformative immunoassay technology which integrates an innovatively designed microfluidic ...
(Date:1/22/2015)... DUBLIN , Jan. 22, 2015 Research and Markets ... of the "Infectious Disease Diagnostics Market by Product, ... report to their offering. , The ... CAGR of 7.9% to reach $18,156.2 million by 2019 ...
(Date:1/22/2015)... The Parenteral Drug Association (PDA) today announced the launch ... Pharmaceutical Manufacturing,s Future. The Manufacturing Science ... , Highlight the ongoing focus PDA has on pharmaceutical and ... filling known gaps in current manufacturing science as well as ...
Breaking Medicine Technology:Bio-Techne Launches Simple Plex Platform 2Bio-Techne Launches Simple Plex Platform 3Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 2Global Infectious Disease Diagnostics (Instruments, Reagents, Services, Software) Market - Forecast to 2019 3PDA Launches Manufacturing Science Program(SM) 2PDA Launches Manufacturing Science Program(SM) 3
... MedImmune today announced,that it has initiated a Phase ... healthy children one month to 12 months of age ... is,the most common respiratory infection in infants and can ... is a serious respiratory disease that can have significant ...
... Meeting -, - Conference call to be hosted ... BRANFORD, Conn., Nov. 3 CuraGen Corporation,(Nasdaq: CRGN ... II,trial of CR011-vcMMAE, an antibody-drug conjugate that targets GPNMB, ... Stage IV melanoma.,Dr. Patrick Hwu, Co-Principal Investigator, and Professor ...
Cached Medicine Technology:MedImmune Advances Pediatric Disease Prevention Program With Start of Phase 1/2a Clinical Trial for Respiratory Syncytial Virus Vaccine 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 2CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 3CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 4CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 5CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 6CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma 7
(Date:1/22/2015)... AZ (PRWEB) January 22, 2015 Padre Murphy's ... long supporter of Pro Player Health Alliance (PPHA). ... Padre Murphy's in getting everyone, including NFL greats, treated for ... of the leading groups supporting the cause in the valley. ...
(Date:1/22/2015)... AngelWeddingDress, the premier women’s dress supplier, has recently ... View website of AngelWeddingDress.com to find more details. ... online for a bridal party. AngelWeddingDress offers a variety ... Its maternity wedding dresses are specially designed for 2015. ...
(Date:1/22/2015)... Autocarinsurancebest.com has released a new blog post explaining the main ... , Auto insurance quotes help many drivers find the ... to call an agent or visit an agency for price ... website: http://autocarinsurancebest.com/ . , Every business who relies heavily ...
(Date:1/22/2015)... Calif. (PRWEB) January 22, 2015 ... Susan Bonilla (D-Concord) and Kristin Olsen (R-Modesto) were ... their leadership in advancing biotechnology, biomedical science, medical ... and Olsen each received the “2014 Life Sciences ...
(Date:1/22/2015)... EBSCO Information Services (EBSCO) and the ... in an effort to further promote visibility and adoption of ... long made AMA journals available via its subscription services, EBSCO ... Network. , Long known as both a subscription ...
Breaking Medicine News(10 mins):Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 2Health News:Padre Murphy's Holds NFL Retired Players Association Party Star Studded Event With Bud Light and Pro Player Health Alliance Sponsoring 3Health News:AngelWeddingDress Has Recently Released Its Collection Of 2015 Maternity Wedding Dresses 2Health News:Commercial Auto Insurance Provides Several Important Features! 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 2Health News:California Biomedical Community Honors Senator Holly Mitchell, Assemblymembers Susan Bonilla & Kristin Olsen 3Health News:EBSCO Expands Partnership with the American Medical Association 2Health News:EBSCO Expands Partnership with the American Medical Association 3Health News:EBSCO Expands Partnership with the American Medical Association 4
... , August is National ... Pa., Aug. 3 Department of Health Secretary Everette James ... Immunization Awareness Month. , , "Recommended vaccinations ... you and your family are up-to-date on these immunizations is ...
... to settle debate over their usefulness , MONDAY, Aug. 3 ... wearing surgical face masks to ward off the flu, and ... up the confusion. , Researchers in Hong Kong found that ... can help keep transmission rates for the seasonal flu down, ...
... , , , BEDFORD, Mass., Aug. ... leading developer, manufacturer and supplier of premium diagnostics, medical imaging systems and surgical products ... quarter ended June 27, 2009. , , Highlights of the ... Revenues of $403.1 million. , Third quarter 2009 ...
... Results , , , ... announced today financial results for the three months ended June 30, 2009. ... 2009, compared to $6.3 million for the same period in 2008. ... million, compared to a net loss of $8.6 million for the same ...
... , , WASHINGTON, Aug. 3 ... top Catholic charitable organizations to condemn the Obama healthcare plan in ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081105/DC44231LOGO ) , ... de Paul and the Catholic Health Association are urging their members ...
... finds increases in use of other psychotropic medications , ... U.S. residents almost doubled between 1996 and 2005, along ... psychotropic medications, a new report shows. , The increase ... 10 percent of people over the age of 6 ...
Cached Medicine News:Health News:Corrected: Secretary of Health Urges Pennsylvanians to Get Immunized 2Health News:Corrected: Secretary of Health Urges Pennsylvanians to Get Immunized 3Health News:Surgical Masks Help Ward Off Flu, Maybe 2Health News:Surgical Masks Help Ward Off Flu, Maybe 3Health News:Surgical Masks Help Ward Off Flu, Maybe 4Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 2Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 3Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 4Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 5Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 6Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 7Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 8Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 9Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 10Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 11Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 12Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 13Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 14Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 15Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 16Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 17Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 18Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 19Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 20Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 21Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 22Health News:Hologic Announces Third Quarter Fiscal 2009 Operating Results 23Health News:DURECT Corporation Announces Second Quarter 2009 Financial 2Health News:DURECT Corporation Announces Second Quarter 2009 Financial 3Health News:DURECT Corporation Announces Second Quarter 2009 Financial 4Health News:DURECT Corporation Announces Second Quarter 2009 Financial 5Health News:DURECT Corporation Announces Second Quarter 2009 Financial 6Health News:DURECT Corporation Announces Second Quarter 2009 Financial 7Health News:DURECT Corporation Announces Second Quarter 2009 Financial 8Health News:DURECT Corporation Announces Second Quarter 2009 Financial 9
... images are transmitted through sorted ... picture and transmit it to ... flexoscopes are designed for rough, ... repaired at low cost if ...
Bipolar gingivoplasty loop. Individual sterile packs....
Electric high speed system....
The XK-PRO 100 High Speed Drill System is a compact, lightweight design that offers new technological and performance standards for a combination of surgical procedures....
Medicine Products: